About the Study

Alagille Syndrome: A clinical study of odevixibat in infants with Alagille syndrome.

This study is enrolling participants who: - Have a diagnosis of Alagille syndrome - Are <1 year of age Alagille syndrome is a rare disease that can cause problems in the liver. The purpose of this study is to see if odevixibat is safe, tolerable and effective in treating infants with Alagille syndrome.

Interested in learning more?

Full Study Name: Ipsen A4250-015 ASSERT-EXT